Title: Long-term Exposure to Sorafenib of Liver Cancer Cells Induces Resistance with Epithelial-to-Mesenchymal Transition, Increased Invasion and Risk of Rebound Growth
Authors: van Malenstein, Hannah ×
Dekervel, Jeroen
Verslype, Chris
Van Cutsem, Eric
Windmolders, Petra
Nevens, Frederik
van Pelt, Jos #
Issue Date: Feb-2013
Publisher: Elsevier
Series Title: Cancer letters vol:329 issue:1 pages:74-83
Article number: S0304-3835(12)00626-X
Abstract: Sorafenib leads to a survival benefit in patients with advanced hepatocellular carcinoma but its use is hampered by the occurrence of drug resistance. To investigate the molecular mechanisms involved we developed five resistant human liver cell lines in which we studied morphology, gene expression and invasive potential. The cells changed their appearance, lost E-cadherin and KRT19 and showed high expression of vimentin, indicating epithelial-to-mesenchymal transition. Resistant cells showed reduced adherent growth, became more invasive and lost liver-specific gene expression. Furthermore, following withdrawal of sorafenib, the resistant cells showed rebound growth, a phenomenon also found in patients. This cell model was further used to investigate strategies for restoration of sensitivity to sorafenib.
ISSN: 0304-3835
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Hepatology
Clinical Digestive Oncology (+)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science